Shionogi Inc. and Purdue Pharma L.P. announced that the FDA approved Symproic (naldemedine) 0.2 mg tablets C-II as a once-daily...
Collegium Pharmaceutical, Inc. and Biodelivery Sciences International, Inc. announced a definitive agreement pursuant to which Collegium will acquire BDSI for $5.60 per share in cash.